TYP
Click for more information
5.56% 1.9¢ tryptamine therapeutics limited

My take on the announcement were the positives of no adverse...

  1. Kriztian
    626 Posts.
    lightbulb Created with Sketch. 41
    clock Created with Sketch.
    01/04/21
    14:19
    Post #: 52207462
    My take on the announcement were the positives of no adverse effects detected and the potential to develop into an effective treatment of osteoarthritis in humans so am holding and looking to buy more at these prices (hopefully) once I have the funds to do so!
    EX1 Price at posting: 59.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 4  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Outstanding metallurgical results significantly de-risk Mandilla gold project
right-arrow Created with Sketch.
NEWS The psychology of spending: How to manage finances wisely
right-arrow Created with Sketch.
EBR $50M capital raise to scale EBR’s WiSE® System – FDA approval expected in 2025
right-arrow Created with Sketch.
NEWS $11.1M capital raise secured – CEO leads $1M push to fast-track alzheimers trial
right-arrow Created with Sketch.
NEWS High-grade niobium extended across multiple targets
right-arrow Created with Sketch.
NEWS Rate cuts, assassination attempts, gold, oil, AI – what to watch in USA this week
right-arrow Created with Sketch.
watchlist Created with Sketch. Add TYP (ASX) to my watchlist
(20min delay)
Last
1.9¢ 		Change
0.001(5.56%) 		Mkt cap ! $20.69M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $4.75K 250K

Buyers (Bids)

No. Vol. Price($)
3 580555 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 1166336 4
View Market Depth
Last trade - 13.01pm 18/09/2024 (20 minute delay) ?
TYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.